Financials
- Market Capitalization 2.54 B
- Employee 177
- Founded 2006
- CEO N/A
- Website www.immunome.com
- Headquarter Delaware, United States
- FIGI BBG00BR93ZG8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-9.15
ratio cours/chiffre d'affaires
112.46
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1837 | QURE uniQure N.V. - Ordinary Shares | 40.66 USD | -2.07% | -3.19% | +46.63% | +188.98% | 2.56 B USD | ||
| 1847 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 13.05 USD | -2.54% | +2.51% | +71.71% | +579.69% | 2.43 B USD | ||
| 1855 | TRVI Trevi Therapeutics, Inc. - Common Stock | 17.48 USD | -2.40% | -4.27% | +19.15% | +154.81% | 2.48 B USD | ||
| 1875 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.45 USD | -2.98% | -11.27% | +3.96% | +8.00% | 2.40 B USD |